When Oxybutynin Becomes a Decoy for Oxycodone: A Case Report of Diversion Through Substitution

This case report describes the novel use of oxybutynin and acetaminophen as a substitution for oxycodone for the express purpose of diverting oxycodone in a hospital-based post-anesthesia care unit (PACU). The report outlines how the physical properties and pharmacologic effects of non-controlled medications in the PACU, like oxybutynin, can be visually mistaken and even mimic the side effects of controlled substances like oxycodone. Substituting oxybutynin for controlled substances can circumvent diversion surveillance software. The authors describe how the diversion was identified and the process improvements that should be implemented for proactive identification moving forward.

Authors

Institutions

Publication Details

Journal
Drug Testing and Analysis
Published
2024-09-17
DOI
https://doi.org/10.1002/dta.3802
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When Oxybutynin Becomes a Decoy for Oxycodone: A Case Report of Diversion Through Substitution

Aram S. Mardian, Ricardo Verdiner, Adam J. Milam, Lynsey A. Seim et al.
Drug Testing and Analysis
Pharmaceutical Practices and Patient Outcomes
article

When Oxybutynin Becomes a Decoy for Oxycodone: A Case Report of Diversion Through Substitution

Aram S. Mardian, Ricardo Verdiner, Adam J. Milam, Lynsey A. Seim, Alissa Voils, Krystal Koball, Maxwell Verdiner
article en

Abstract

This case report describes the novel use of oxybutynin and acetaminophen as a substitution for oxycodone for the express purpose of diverting oxycodone in a hospital-based post-anesthesia care unit (PACU). The report outlines how the physical properties and pharmacologic effects of non-controlled medications in the PACU, like oxybutynin, can be visually mistaken and even mimic the side effects of controlled substances like oxycodone. Substituting oxybutynin for controlled substances can circumvent diversion surveillance software. The authors describe how the diversion was identified and the process improvements that should be implemented for proactive identification moving forward.

Drug Testing and AnalysisVol. 17(7)
Mayo Clinic (US), University of Arizona (US), Jacksonville College (US), Phoenix VA Health Care System (US), Mayo Clinic Hospital (US), Mayo Clinic in Florida (US)
Good health and well-being
Openalex Percentile: Top 79%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.